Home  »  Stock   »  ReShape Lifesciences Inc. (RSLS): Ready for an exp...

ReShape Lifesciences Inc. (RSLS): Ready for an explosive trading day

Let’s start up with the current stock price of ReShape Lifesciences Inc. (RSLS), which is $0.16 to be very precise. The Stock rose vividly during the last session to $0.18 after opening rate of $0.18 while the lowest price it went was recorded $0.1484 before closing at $0.17.Recently in News on November 14, 2022, ReShape Lifesciences™ Reports Third Quarter 2022 Financial Results and Provides Corporate Update. Conference Call to be Held at 8:00 am ET Today. You can read further details here

ReShape Lifesciences Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $1.8600 on 01/03/22, with the lowest value was $0.1484 for the same time period, recorded on 11/23/22.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


ReShape Lifesciences Inc. (RSLS) full year performance was -92.04%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, ReShape Lifesciences Inc. shares are logging -92.80% during the 52-week period from high price, and 5.47% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.15 and $2.22.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1700588 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the ReShape Lifesciences Inc. (RSLS) recorded performance in the market was -90.25%, having the revenues showcasing -63.02% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 3.78M, as it employees total of 47 workers.

ReShape Lifesciences Inc. (RSLS) in the eye of market guru’s

During the last month, 0 analysts gave the ReShape Lifesciences Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.3831, with a change in the price was noted -0.42. In a similar fashion, ReShape Lifesciences Inc. posted a movement of -72.43% for the period of last 100 days, recording 352,966 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for RSLS is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.

ReShape Lifesciences Inc. (RSLS): Stocks Technical analysis and Trends

Raw Stochastic average of ReShape Lifesciences Inc. in the period of last 50 days is set at 4.45%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 6.00%. In the last 20 days, the company’s Stochastic %K was 6.08% and its Stochastic %D was recorded 6.82%.

If we look into the earlier routines of ReShape Lifesciences Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -90.25%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -77.48%, alongside a downfall of -92.04% for the period of the last 12 months. The shares increased approximately by -27.75% in the 7-day charts and went up by -48.42% in the period of the last 30 days. Common stock shares were lifted by -63.02% during last recorded quarter.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts